BioStable Science & Engineering Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
BioStable Science & Engineering General Information
Description
Developer of cardiovascular valve repair technologies designed to provide an alternative to valve replacement for patients with aortic valve disease. The company's technologies are designed to simplify and standardize aortic valve repair, including annuloplasty devices, instrumentation, and repeatable implantation procedures, enabling surgeons to offer the recognized clinical benefits of valve repair to patients undergoing surgical correction of aortic insufficiency or aortic root aneurysm.
Contact Information
Website
www.biostable-s-e.comCorporate Office
- 2621 Ridgepoint Drive
- Suite 100
- Austin, TX 78754
- United States
Corporate Office
- 2621 Ridgepoint Drive
- Suite 100
- Austin, TX 78754
- United States
BioStable Science & Engineering Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 28-Apr-2023 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 01-Feb-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 21-Feb-2020 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 29-Apr-2015 | Completed | Startup | |||
| 2. Early Stage VC (Series B) | 28-Dec-2012 | $6.5M | $12M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 22-Aug-2008 | $5.5M | $5.5M | Completed | Startup |
BioStable Science & Engineering Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 3,374,792 | $0.001000 | $0.16 | $2 | $2 | 1x | $2 | 21.42% |
BioStable Science & Engineering Comparisons
Industry
Financing
Details
BioStable Science & Engineering Competitors (21)
One of BioStable Science & Engineering’s 21 competitors is NeoChord, a Venture Capital-Backed company based in Maple Grove, MN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NeoChord | Venture Capital-Backed | Maple Grove, MN | ||||
| Cardiac Dimensions | Venture Capital-Backed | Kirkland, WA | ||||
| Biotronik | Corporate Backed or Acquired | Berlin, Germany | ||||
| Söring | Private Equity-Backed | Quickborn, Germany | ||||
| Spine Wave | Venture Capital-Backed | Shelton, CT |
BioStable Science & Engineering Patents
BioStable Science & Engineering Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2813254-A1 | Aortic valve devices | Inactive | 30-Sep-2010 | ||
| EP-2621408-A2 | Aortic valve devices | Active | 30-Sep-2010 | ||
| EP-2621408-B1 | Aortic valve devices | Active | 30-Sep-2010 | ||
| ES-2583629-T3 | Aortic valve devices | Active | 30-Sep-2010 | ||
| CA-2813246-A1 | Intra-annular mounting frame for aortic valve repair | Inactive | 30-Sep-2010 | A61F2/2418 |
BioStable Science & Engineering Signals
BioStable Science & Engineering Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Longmeadow Capital Partners | PE/Buyout | Minority | ||
| Louisiana Funds | Venture Capital | Minority | ||
| Orlando Health Ventures | Corporate Venture Capital | Minority | ||
| Santen Ventures | Corporate Venture Capital | Minority | ||
| Santé Ventures | Venture Capital | Minority |
BioStable Science & Engineering FAQs
-
When was BioStable Science & Engineering founded?
BioStable Science & Engineering was founded in 2008.
-
Where is BioStable Science & Engineering headquartered?
BioStable Science & Engineering is headquartered in Austin, TX.
-
What is the size of BioStable Science & Engineering?
BioStable Science & Engineering has 4 total employees.
-
What industry is BioStable Science & Engineering in?
BioStable Science & Engineering’s primary industry is Surgical Devices.
-
Is BioStable Science & Engineering a private or public company?
BioStable Science & Engineering is a Private company.
-
What is BioStable Science & Engineering’s current revenue?
The current revenue for BioStable Science & Engineering is .
-
How much funding has BioStable Science & Engineering raised over time?
BioStable Science & Engineering has raised $22.8M.
-
Who are BioStable Science & Engineering’s investors?
Longmeadow Capital Partners, Louisiana Funds, Orlando Health Ventures, Santen Ventures, and Santé Ventures are 5 of 8 investors who have invested in BioStable Science & Engineering.
-
Who are BioStable Science & Engineering’s competitors?
NeoChord, Cardiac Dimensions, Biotronik, Söring, and Spine Wave are some of the 21 competitors of BioStable Science & Engineering.
-
When was BioStable Science & Engineering acquired?
BioStable Science & Engineering was acquired on 28-Apr-2023.
-
Who acquired BioStable Science & Engineering?
BioStable Science & Engineering was acquired by Corcym.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process